PMV Pharmaceuticals Inc (PMVP)
1.92
+0.05
(+2.67%)
USD |
NASDAQ |
May 03, 13:09
PMV Pharmaceuticals 1 Year Total Returns (Daily): -58.17% for May 2, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 02, 2024 | -58.17% |
| May 01, 2024 | -60.00% |
| April 30, 2024 | -60.95% |
| April 29, 2024 | -61.61% |
| April 26, 2024 | -60.76% |
| April 25, 2024 | -61.49% |
| April 24, 2024 | -61.24% |
| April 23, 2024 | -62.08% |
| April 22, 2024 | -63.66% |
| April 19, 2024 | -65.60% |
| April 18, 2024 | -63.35% |
| April 17, 2024 | -64.77% |
| April 16, 2024 | -63.55% |
| April 15, 2024 | -62.76% |
| April 12, 2024 | -56.97% |
| April 11, 2024 | -61.18% |
| April 10, 2024 | -61.68% |
| April 09, 2024 | -61.46% |
| April 08, 2024 | -61.95% |
| April 05, 2024 | -62.70% |
| April 04, 2024 | -62.53% |
| April 03, 2024 | -63.44% |
| April 02, 2024 | -62.47% |
| April 01, 2024 | -62.68% |
| March 28, 2024 | -65.02% |
| Date | Value |
|---|---|
| March 27, 2024 | -67.33% |
| March 26, 2024 | -67.00% |
| March 25, 2024 | -66.20% |
| March 22, 2024 | -65.86% |
| March 21, 2024 | -68.27% |
| March 20, 2024 | -69.58% |
| March 19, 2024 | -68.99% |
| March 18, 2024 | -69.36% |
| March 15, 2024 | -68.29% |
| March 14, 2024 | -70.80% |
| March 13, 2024 | -71.07% |
| March 12, 2024 | -69.33% |
| March 11, 2024 | -69.70% |
| March 08, 2024 | -70.99% |
| March 07, 2024 | -69.05% |
| March 06, 2024 | -66.72% |
| March 05, 2024 | -68.14% |
| March 04, 2024 | -68.31% |
| March 01, 2024 | -69.71% |
| February 29, 2024 | -74.34% |
| February 28, 2024 | -74.90% |
| February 27, 2024 | -74.25% |
| February 26, 2024 | -74.86% |
| February 23, 2024 | -77.09% |
| February 22, 2024 | -76.96% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-89.81%
Minimum
Oct 25 2023
-8.92%
Maximum
Oct 05 2021
-57.78%
Average
-57.15%
Median
1 Year Total Returns (Daily) Benchmarks
| Exelixis Inc | 17.47% |
| Geron Corp | 59.27% |
| Verastem Inc | 98.28% |
| Karyopharm Therapeutics Inc | -69.55% |
| Kura Oncology Inc | 101.6% |